| Medicine trade is an important constituent part of Chinese national economy. It is the combination of traditional industry and modern industry and the combination of the first, second and third industry. A series of shakes of medicine environment bring lots of uncertainties to medicine companies'marketing, such as separation of treatment and medicine since 1998, agreement for entering WTO between China and America in the 15th, Nov. of 1999 and authentication compulsion of medicine production companies in July of 2004, and therefore which leads to more difficulties for survival, reasonably speaking, the changing environment has established the foundation for depreciation of medicine price. On the other hand, continuous depreciation of medicine price for 17 times since 1996, which was intervened and forced by relative ministries of China, 40 billion RMB has been cut down in total, but the customers didn't benefit from the measures. Entering WTO provides a new market for domestic medicine economy and meanwhile pushes transforms of trades of medical sanitation, medicine companies and medicine circulation. Facing up the changeful environment of medicine market, how to develop themselves for medicine companies, channels of circulation, medical organizations and government is still a problem.China is the second country of medicine production, the sorts and quantities of medicine production are enlarged gradually. From 1978 to 2001, medicine industry kept a quick speed of development, calculated by total production value of industry, the rate of increase per year is up to 16.6%, it is one of the trades that develop fastest of national economy. The data of the past 11 years show that the total production value of medicine trade closely in relation to domestic total production value. The increase scale of medicine industry fluctuated with the increase scale of domestic total production value, but the former is always above the latter several percents. During these years, China carries out the complete innovations of medical system, such as medicine management by classification, depreciation of medicine price, medicine bidding and stock and so on; policies of quality authentication of GMP and GSP influence the... |